Treatment

RGX-202 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2, PHASE3
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
This study is testing a new gene therapy called RGX-202 for boys with Duchenne muscular dystrophy. It aims to see if it's safe and helps muscles work better by delivering a special protein that's missing.
For: Duchenne Muscular Dystrophy
United States · Canada